STAT+: Embryo editing advances reignite ethical debates

AI Summary

Advances in embryo editing technologies have reignited ethical debates surrounding biotechnology and healthcare. The article also touches on issues related to biotech industry dynamics such as 340B policies and patient-centric developments.

Cassidy targets 340B, Eli Lilly's mysterious retatrutide patient, and more biotech news from The Readout